Align Secures Patent Victory Against Angel
Summary & scoring by The Bell Brief (Dr. Jennifer Bell) using the Drill-Down Protocol (Drill-Down Score) — not the original publisher.
Why it matters for dental
Align's court win in China blocks Angelalign's clear-aligner products from the market there, protecting Align's IP and reinforcing its competitive position in the fastest-growing orthodontic segment.
Key points
- Align Technology's patent was upheld by the Jinan Intermediate People’s Court, preventing Angelalign’s subsidiaries from selling infringing clear aligners in China.
- China is a high-growth market for clear aligners; enforcement actions like this could slow Angelalign’s expansion and favor Align’s Invisalign System.
- Dental practices and DSOs offering aligner therapy should expect continued market dominance by Align and fewer low-cost domestic competitors in China.
- Patent enforcement trends signal potential future litigation in other regions where Align holds similar IP, increasing legal risk for copy-cat aligner brands.
Who should care
Read the original on Dentistry Today
Full reporting and any paywall content live on dentistrytoday.com. We summarize and score; we do not republish.
Related
- ·Business
Why the dental assistant shortage could get worse
- ·Business
US Oral Surgery Management exec on M&A: ‘We’ve had to be even more disciplined’
- ·Research
Vertical dimension of occlusion restoration using a digital injectable composite resin technique: A 5-year clinical follow-up
- ·Research
A digitally guided workflow integrating tooth preparation and restoration positioning for minimally invasive veneer and partial-coverage restorations: A dental technique